The A-share brain-computer interface concept is actively defying the trend, with BIOTEST BIOTECH rising over 10%, and Meihao Medical, Sanbo, APON, and Xiangyu Medical following suit
Wallstreetcn
The A-share brain-computer interface concept is actively defying the trend, with BIOTEST BIOTECH rising over 10%, and APON, Sanbo, and Xiangyu Medical also following suit
